ReviewESMO gastrointestinal oncology2025

Expanding the potential of antibody-drug conjugates in gastrointestinal malignancies: beyond HER2 targets.

P Ntellas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.